Global Vertigo Drugs Market 2019-2023

The vertigo drugs market size will grow by more than USD 341 million during 2019-2023. This report offers an analysis of the market based on product type (antihistamines, phenothiazines, benzodiazepines, and other drugs). The vertigo drugs market research report further presents in-depth insights into the growth prospects of the market across geographic regions - the Americas, APAC, and EMEA. The report analyzes the market’s competitive landscape and offers information on several vertigo drug companies including F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Pfizer, and Teva Pharmaceutical Industries.

Below are some of the key findings from this vertigo drugs industry analysis report

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE Sample now!

Global vertigo drugs industry overview

Vertigo drugs industry growth is expected to accelerate over the next five years, driven by the high prevalence of risk factors for vertigo. Vertigo mostly occurs due to inner ear infections or other conditions such as benign paroxysmal positional vertigo (BPPV), vestibular neuritis, and Meniere’s disease. The prevalence of these high-risk factors is on the rise globally, and it is estimated that BPPV affects 80 individuals per 1,000 healthy individuals, suffering from moderate or severe vertigo.

Another common cause for vertigo is vestibular neuritis, which is an infection in the inner ears and causes inflammation around the nerves that help the body sense balance resulting in a severe sensation of vertigo that can last for a couple of days and at times coupled with hearing loss. Vestibular neuritis or BPPV may have a lower rate of prevalence individually, however, when combined, these risk factors of vertigo have a higher prevalence rate and forecasted to boost the growth of the global vertigo drugs market for the next five years. The increasing geriatric population will drive the vertigo drugs market to grow at a CAGR of close to 4% during the forecast period.

Top vertigo drug companies covered in this market research report

The vertigo drugs market is highly fragmented with the existence of many vertigo drug manufacturers who offer products such as antihistamines, phenothiazines, benzodiazepines, and other drugs. Many established vertigo drug companies are vying for their share of the global vertigo drugs market, and the new players must differentiate themselves to gain vital traction over their peers. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this vertigo drugs industry analysis report will allow the clients to identify new growth opportunities and design innovative strategies for improving their share in the market.

The report offers a complete analysis of various vertigo drug manufacturers including:

• F. Hoffmann-La Roche
• GlaxoSmithKline
• Novartis
• Pfizer
• Teva Pharmaceutical Industries

Vertigo drugs market segmentation based on geographic regions

• Americas
• APAC
• EMEA

With a complete study of the growth opportunities for the vertigo drug companies, our industry research analysts have estimated the Americas will contribute to the highest growth of this market throughout the forecast period. The high per capita income of countries such as the US and Canada encourage spending on healthcare which is one of the major reasons for the high growth of the vertigo drugs market in this region.

Vertigo drugs market segmentation based on product type

• Antihistamines
• Phenothiazines
• Benzodiazepines
• Other drugs

According to our market research experts, the antihistamines product segment will account for the largest share in the vertigo drugs market. Additionally, the report also provides an accurate prediction of the contribution of the various product segments to the growth of the vertigo drugs market size.

Key highlights of the global vertigo drugs market for the forecast years 2019-2023:

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the vertigo drugs market during the next five years
• Precise estimation of the global vertigo drugs market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the vertigo drugs industry across various geographies such as the Americas, APAC, and EMEA
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive information about factors that will challenge the growth of vertigo drug companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch